Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Roden

Showing results (61-70 of 593) with videos related to

Pageof 60
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 21, 2007
On the relationship among QT interval, atrial fibrillation, and torsade de pointesDan M Roden, Prince Kannankeril, Dawood Darbar
Cardiovascular Research|January 21, 2004
Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoterPing Yang, Sabina Kupershmidt, Dan M Roden
Circulation|July 2, 2003
Phosphorylation of the IKs channel complex inhibits drug block: novel mechanism underlying variable antiarrhythmic drug actionsTao Yang, Hideaki Kanki, Dan M Roden
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 9, 2007
A memorable experienceKen Monahan, Walter Clair, Dan M Roden
Circulation|October 30, 2023
The Shape of Ventricular TachycardiaWilliam G Stevenson, Harikrishna Tandri, Dan M Roden
JAMA|January 4, 2022
Phenome-Wide Association StudiesLisa Bastarache, Joshua C Denny, Dan M Roden
Heart Rhythm|January 25, 2019
Multiple mechanisms underlie increased cardiac late sodium currentBrett M Kroncke, Tao Yang, Dan M Roden
Current Pharmaceutical Design|November 21, 2009
Arrhythmia pharmacogenomics: methodological considerationsDan M Roden, Prince J Kannankeri, Dawood Darbar
Clinical Pharmacology and Therapeutics|March 10, 2021
The Case for Expanding the FDA Box Warning on Clopidogrel to CYP2C19 Intermediate MetabolizersMichelle Liu, Dan M Roden, Josh F Peterson
Circulation|June 22, 2016
The Future of Cardiovascular TherapeuticsCalum A MacRae, Dan M Roden, Joseph Loscalzo
Pageof 60

Showing results (61-70 of 593) with videos related to

Sort By:
Pageof 60
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 21, 2007
On the relationship among QT interval, atrial fibrillation, and torsade de pointesDan M Roden, Prince Kannankeril, Dawood Darbar
Cardiovascular Research|January 21, 2004
Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoterPing Yang, Sabina Kupershmidt, Dan M Roden
Circulation|July 2, 2003
Phosphorylation of the IKs channel complex inhibits drug block: novel mechanism underlying variable antiarrhythmic drug actionsTao Yang, Hideaki Kanki, Dan M Roden
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 9, 2007
A memorable experienceKen Monahan, Walter Clair, Dan M Roden
Circulation|October 30, 2023
The Shape of Ventricular TachycardiaWilliam G Stevenson, Harikrishna Tandri, Dan M Roden
JAMA|January 4, 2022
Phenome-Wide Association StudiesLisa Bastarache, Joshua C Denny, Dan M Roden
Heart Rhythm|January 25, 2019
Multiple mechanisms underlie increased cardiac late sodium currentBrett M Kroncke, Tao Yang, Dan M Roden
Current Pharmaceutical Design|November 21, 2009
Arrhythmia pharmacogenomics: methodological considerationsDan M Roden, Prince J Kannankeri, Dawood Darbar
Clinical Pharmacology and Therapeutics|March 10, 2021
The Case for Expanding the FDA Box Warning on Clopidogrel to CYP2C19 Intermediate MetabolizersMichelle Liu, Dan M Roden, Josh F Peterson
Circulation|June 22, 2016
The Future of Cardiovascular TherapeuticsCalum A MacRae, Dan M Roden, Joseph Loscalzo
Pageof 60